Pierre Gosset Selected Research

Infections

1/2022	Systematic Review and Meta-analysis of Histological Gastric Biopsy Aspects According to the Updated Sydney System in Children.
1/2021	The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice.
12/2017	A one-step immune-chromatographic Helicobacter pylori stool antigen test for children was quick, consistent, reliable and specific.
1/2017	Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease.
1/2017	Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.
9/2015	Usefulness of Gastric Biopsy-Based Real-Time Polymerase Chain Reaction for the Diagnosis of Helicobacter pylori Infection in Children.
6/2015	Alteration or adaptation, the two roads for human gastric mucin glycosylation infected by Helicobacter pylori.
6/2013	Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.
3/2012	Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.
1/2012	Cryptosporidium parvum infection in SCID mice infected with only one oocyst: qPCR assessment of parasite replication in tissues and development of digestive cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Gosset Research Topics

Disease

11	Infections 01/2022 - 12/2009
10	Neoplasms (Cancer) 12/2017 - 12/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 11/2015
4	Prostatic Neoplasms (Prostate Cancer) 03/2017 - 07/2011
3	Lung Neoplasms (Lung Cancer) 04/2018 - 06/2009
3	Pneumonia (Pneumonitis) 01/2017 - 06/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2015
2	Carcinogenesis 01/2018 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2017 - 03/2012
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 03/2015
2	Bacterial Infections (Bacterial Infection) 11/2015 - 06/2013
2	Neoplasm Metastasis (Metastasis) 03/2015 - 12/2013
1	Inflammation (Inflammations) 01/2022
1	Metaplasia 01/2022
1	Atrophy 01/2022
1	Haemophilus Infections 01/2017
1	Airway Remodeling 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Pathologic Processes 01/2017
1	Aberrant Crypt Foci 01/2016
1	Pneumococcal Infections 11/2015
1	Mesothelioma 08/2015
1	Adenocarcinoma of Lung 08/2015
1	Malignant Mesothelioma 08/2015
1	Superinfection 06/2013
1	Human Influenza (Influenza) 06/2013
1	Communicable Diseases (Infectious Diseases) 06/2013
1	Stomach Diseases 09/2012
1	Adenocarcinoma 01/2012
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2012
1	Brain Neoplasms (Brain Tumor) 03/2011

Drug/Important Bio-Agent (IBA)

5	Interleukin-22 (IL-22)IBA 01/2017 - 03/2012
4	SmokeIBA 01/2021 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2011
3	AntigensIBA 12/2017 - 12/2009
3	Ion Channels (Ion Channel)IBA 03/2017 - 12/2013
3	CalciumIBA 03/2017 - 12/2013
3	CytokinesIBA 01/2017 - 03/2012
3	MucinsIBA 01/2015 - 03/2011
2	LigandsIBA 01/2021 - 03/2015
2	FlagellinIBA 01/2021 - 01/2017
2	InterleukinsIBA 01/2021 - 01/2017
2	ParaffinIBA 03/2017 - 07/2011
2	TRPA1 Cation ChannelIBA 03/2017 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2017 - 01/2017
2	Formaldehyde (Formol)FDA Link 03/2017 - 07/2011
2	Gastric MucinsIBA 01/2016 - 06/2015
2	Polysaccharides (Glycans)IBA 06/2015 - 01/2015
1	AntralIBA 01/2022
1	Toll-Like Receptor 5IBA 01/2021
1	Vehicle Emissions (Emissions, Vehicle)IBA 04/2018
1	Biological ProductsIBA 12/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2017
1	Triclosan (pHisoHex)FDA Link 03/2017
1	CationsIBA 03/2017
1	5-aminolevulinic acid hexyl ester FDA Link 01/2017
1	ResveratrolIBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	AnkyrinsIBA 01/2017
1	Fluorescein (Funduscein)FDA LinkGeneric 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Contrast MediaIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 11/2015
1	UreaseIBA 09/2015
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2015
1	ClaudinsIBA 08/2015
1	Claudin-3IBA 08/2015
1	Chemokine ReceptorsIBA 03/2015
1	Pharmaceutical PreparationsIBA 03/2015
1	ChemokinesIBA 03/2015
1	Calcium Channels (Calcium Channel)IBA 09/2014
1	Proteins (Proteins, Gene)FDA Link 12/2013
1	MetalsIBA 12/2013
1	bisphenol AIBA 12/2013
1	PlasticsIBA 12/2013
1	CarbohydratesIBA 09/2012
1	EpitopesIBA 09/2012
1	LipidsIBA 03/2012
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2012
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	Cysteine (L-Cysteine)FDA Link 03/2011
1	Scavenger Receptors (Scavenger Receptor)IBA 03/2011
1	CarcinogensIBA 06/2009

Therapy/Procedure

1	Lasers (Laser) 01/2017
1	Aftercare (After-Treatment) 01/2016
1	Therapeutics 08/2015
1	Neoadjuvant Therapy 03/2015
1	Drug Therapy (Chemotherapy) 03/2015
1	Adjuvant Chemotherapy 01/2015